Scarica l'app Stockscreener
41.76
0.36%
-0.15
Pre-mercato:
42.22
0.46
+1.10%
Qiagen Nv Borsa (QGEN) Ultime notizie
Qiagen N.V. stock (NL0012169213): Why does its sample-to-insight business model matter more for U.S. - AD HOC NEWS
QIAGEN launches bloodstream infection testing panel - StreetInsider
QIAGEN (QGEN) Launches New Panel for Bloodstream Infections - GuruFocus
Qiagen launches bloodstream infection testing panel By Investing.com - Investing.com Canada
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel - Business Wire
Barclays Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $44 - Moomoo
QIAGEN NV : Barclays is less optimistic - marketscreener.com
Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48 - marketscreener.com
Qiagen N.V. stock (NL0012169213): Is sample-to-insight leadership strong enough to unlock new upside - AD HOC NEWS
Precision Trading with Qiagen N.v. (QGEN) Risk Zones - Stock Traders Daily
Qiagen N.V. stock (NL0012169213): Why does its molecular diagnostics edge matter more now for U.S. i - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): Is its genomics leadership strong enough to unlock new upside? - AD HOC NEWS
Qiagen N.V. stock (NL0012169213): Does its genomics leadership deliver the biotech stability U.S. in - AD HOC NEWS
Big Money Moves: Is Qiagen NV backed by strong institutional buying2026 Price Momentum & Detailed Earnings Play Strategies - baoquankhu1.vn
Massachusetts Financial Services Co. MA Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Trading Recap: Is Qiagen NV backed by strong institutional buyingTrade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Chipmakers Recap: Is Qiagen NV exposed to political risk2026 Biggest Moves & Fast Moving Stock Trade Plans - baoquankhu1.vn
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Fed Watch: Why is Qiagen NV stock going up2026 Institutional Moves & Expert Curated Trade Setup Alerts - baoquankhu1.vn
QGEN Stock Price, Quote & Chart | QIAGEN N.V. (NYSE:QGEN) - ChartMill
BlackRock Discloses Double-Digit Stake in Qiagen - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
QGEN PE Ratio & Valuation, Is QGEN Overvalued - Intellectia AI
How Investors May Respond To Qiagen (QGEN) Upgrade After Reaffirmed 5% Outlook And New Product Plans - Sahm
Aug Levels: How does Qiagen NV score in quality rankingsQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Qiagen (QGEN) upgraded to buy by Deutsche Bank after 30% decline - MSN
Momentum Shift: Why is Qiagen NV stock going up2026 Pullback Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
QGEN Technical Analysis & Stock Price Forecast - Intellectia AI
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access - MSN
Qiagen N.V. (QIA.DE) stock price, news, quote and history - Yahoo Finance UK
Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider - GlobeNewswire Inc.
Bank of America Discloses 3.01% Voting Stake in Qiagen - TipRanks
Qiagen (QGEN) Upgraded to Buy by Deutsche Bank After 30% Decline - Insider Monkey
Bruker appoints QIAGEN CEO Thierry Bernard to board of directors By Investing.com - Investing.com South Africa
Qiagen N.V. Stock: Leader in Molecular Diagnostics Faces CEO Transition Amid Steady Growth Outlook - AD HOC NEWS
Bruker appoints QIAGEN CEO Thierry Bernard to board of directors - Investing.com
Bruker brings in QIAGEN chief Thierry Bernard for board seat - Stock Titan
List of 26 Acquisitions by Qiagen (Apr 2026) - Tracxn
Bear Alert: Whats next for Qiagen NV stock2026 Weekly Recap & Risk Managed Investment Strategies - baoquankhu1.vn
Qiagen N.V. Stock: Oversold Opportunity in Sample-to-Insight Leader Amid Biotech Sector Shifts - AD HOC NEWS
Allspring Global Investments Holdings LLC Boosts Position in Qiagen N.V. $QGEN - MarketBeat
QIAGEN NV Hits New 52-Week Low at USD 38.80 Amid Declining Performance - Markets Mojo
AlphaValue/Baader Europe Upgrades Qiagen to Buy - marketscreener.com
The Bull Case For Qiagen (QGEN) Could Change Following New QuantiFERON-TB Gold Plus EvidenceLearn Why - simplywall.st
Qiagen (QGEN) Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection - Sahm
Qiagen NV at Leerink Global Healthcare Conference Transcript - GuruFocus
Qiagen (NYSE:QGEN) Cut to "Hold" at Wall Street Zen - MarketBeat
Qiagen N.V. Stock: Steady Position in Molecular Diagnostics Amid Sector Growth Opportunities - AD HOC NEWS
Qiagen (NYSE:QGEN) Sets New 52-Week LowTime to Sell? - MarketBeat
Aug Highlights: Should I set a stop loss on Qiagen NVProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Qiagen N.V. Stock: A Core Player in Molecular Diagnostics for Long-Term Investor Focus - AD HOC NEWS
QIAGEN NV Hits New 52-Week Low at USD 39.26 Amid Ongoing Decline - Markets Mojo
Qiagen N.V. stock faces pressure amid biotech sector volatility and recent market caution - AD HOC NEWS
Qiagen N.V. stock faces pressure amid biotech sector volatility and recent price dip on Frankfurt ex - AD HOC NEWS
Portfolio Update: How does Qiagen NV score in quality rankings2026 Geopolitical Influence & Verified Short-Term Plans - baoquankhu1.vn
Aug Gainers: Can Qiagen NV ride the EV waveTrade Volume Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
0.65%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):